![](/img/cover-not-exists.png)
5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis : Can we safely reduce the dose of administered agents?
Matti Aapro, Peter BlowerVolume:
104
Year:
2005
Language:
english
Pages:
18
DOI:
10.1002/cncr.21141
File:
PDF, 223 KB
english, 2005